Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts
- 1 October 2001
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 28 (8) , 725-735
- https://doi.org/10.1038/sj.bmt.1703254
Abstract
Autologous stem cell transplantation appears to enhance outcome in multiple myeloma patients. To improve upon these results, various groups have utilized tandem autografts, as well as used reduced-conditioning allogeneic stem cell transplantation. These two approaches, discussed herein, have been promising. Inherent patient selection, however, appears to play a role and much of the data have not yet been subjected to peer-review scrutiny. At present, these strategies remain investigational and cannot be considered the standard-of-care for multiple myeloma patients.Keywords
This publication has 63 references indexed in Scilit:
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myelomaBone Marrow Transplantation, 1999
- Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myelomaBone Marrow Transplantation, 1999
- Graft-versus-myelomaBone Marrow Transplantation, 1998
- High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiencyBone Marrow Transplantation, 1997
- High-dose chemotherapy with carboplatin, cyclophosphamide and etoposide and autologous transplantation for multiple myeloma relapsing after a previous transplantBone Marrow Transplantation, 1997
- Autologous and allogeneic transplantation for multiple myeloma at a single centreBone Marrow Transplantation, 1997
- Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantationBone Marrow Transplantation, 1997
- Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effectLeukemia, 1997
- Graft-versus-myeloma effect in two casesThe Lancet, 1996